Famela Ramos
Corporate Officer/Principal bei THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Vermögen: 6 000 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Famela Ramos
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Other | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Famela Ramos
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| MEDISTEM INC | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
Emvolio, Inc.
 Emvolio, Inc. Pharmaceuticals: MajorHealth Technology Emvolio, Inc. develops cancer drugs. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| MxThree Dimensional Media Ic | President | ||
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Central South University | College/University | Doctorate Degree | |
| RIVULET MEDIA, INC. | Data Processing Services | Chief Tech/Sci/R&D Officer | |
| SuperView Biotechnology Co. Ltd. | Chief Tech/Sci/R&D Officer | ||
Sanford Burnham Prebys Medical Discovery Institute
 Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
MolecuVax, Inc.
 MolecuVax, Inc. BiotechnologyHealth Technology MolecuVax, Inc. manufactures biopharmaceutical products. It offers MVAX-001, a cancer stem cell targeted immunotherapy that activates the immune system to seek and destroy cancer stem cells based on their expression of a protein named Brother of the Regulator of Imprinted Sites (BORIS). The company is headquartered in Oceanside, CA. | Biotechnology | Chairman | |
OmniBiome, Inc.
 OmniBiome, Inc. Medical SpecialtiesHealth Technology OmniBiome, Inc. manufactures diagnostic kits. It focuses on developing Dx/Rx products and services for pre-pregnancy-associated and pregnancy-associated conditions or diseases where there is a substantive putative link with microbiome dysbiosis, as well as on restoring eubiosis. The company is headquartered in Oceanside, CA. | Medical Specialties | Chairman | |
Capo Therapeutics, Inc.
 Capo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Capo Therapeutics, Inc. develops peptide and epitope vaccines for Alzheimer’s disease. The company is headquartered in Oceanside, CA. | Pharmaceuticals: Major | Director/Board Member | |
| TMD Courses, Inc. | Investment Managers | President | |
Sandbox Dental Labs, Inc.
 Sandbox Dental Labs, Inc. Medical/Nursing ServicesHealth Services Sandbox Dental Labs, Inc. operates a dental laboratory. | Medical/Nursing Services | Chairman | |
| University of California San Diego | College/University | Undergraduate Degree | |
| Ross University School of Medicine | College/University | Doctorate Degree | |
San Diego Critical Care Medical Group, Inc.
 San Diego Critical Care Medical Group, Inc. Medical/Nursing ServicesHealth Services San Diego Critical Care Medical Group, Inc. is an American company that operates as medical experts providing hospitalist care services. The private company is based in La Mesa. | Medical/Nursing Services | Corporate Officer/Principal | |
Sharp Grossmont Hospital
 Sharp Grossmont Hospital Hospital/Nursing ManagementHealth Services Sharp Grossmont Hospital operates hospitals. The private company is based in La Mesa. | Hospital/Nursing Management | Corporate Officer/Principal | |
| ENTEST GROUP, INC. | Financial Conglomerates | Chief Tech/Sci/R&D Officer | |
| Society of Clinical Research Associates | Corporate Officer/Principal | ||
| Carbon Manna UC | Director/Board Member | ||
| University of Science, Arts & Technology | College/University | Doctorate Degree | |
Tolerotech, Inc.
 Tolerotech, Inc. Medical SpecialtiesHealth Technology ToleroTech Technology, Inc. operates as a biopharmaceutical firm. It develops and commercializes different medical products. The company was founded by Thomas E. Ichim and is headquartered in London, Canada. | Medical Specialties | Founder | |
| MedVax Pharma Corp. | Chief Executive Officer | ||
| Oncomune LLC | Founder | ||
| REGEN BIOPHARMA, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| The University of Waterloo | College/University | Undergraduate Degree | |
Creative Medical Health, Inc.
 Creative Medical Health, Inc. Pharmaceuticals: OtherHealth Technology Creative Medical Health, Inc. manufactures bionutraceutical products. It portfolio of stem cell treatments including our patented caver stem, procedure for the treatment of erectile dysfunction with the use of the patients own stem cells, treatment of Type 2 diabetes, degenerative disc disease, cardio vascular disease and autoimmune diseases all utilize cutting edge stem cell technology, developed by leaders in the fields of Science and Medicine. The company is headquartered in Phoenix, AZ. | Pharmaceuticals: Other | Director/Board Member | |
| Riordan Clinic Inc | Director/Board Member | ||
Batu Biologics, Inc.
 Batu Biologics, Inc. Pharmaceuticals: MajorHealth Technology Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder | |
| University of Western Ontario | College/University | Graduate Degree | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Creative Medical Technologies, Inc.
 Creative Medical Technologies, Inc. BiotechnologyHealth Technology Creative Medical Technologies, Inc. develops novel regenerative medicine and stem cell technologies. The company was founded on December 3, 1998 and is headquartered in Phoenix, AZ. | Biotechnology | President | |
Biorasi LLC
 Biorasi LLC BiotechnologyHealth Technology Biorasi LLC operates as a contract research organization specializes in the development of therapeutics. It provides services, including program management, regulatory services, including trial approval services, interim and post trial regulatory management, and marketing approval/registration services and clinical services, including training, monitoring, and issue resolution. The company was founded by Boris N. Reznik in 2002 and is headquartered in Miami, FL. | Biotechnology | Founder | |
Nobilis Therapeutics, Inc.
 Nobilis Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nobilis Therapeutics, Inc. develops inhalation-based therapeutics for the treatment of neurologic, psychiatric, and development disorders. It develops gas mixtures that offer reproducible, standardized, and controlled patient exposure to address unmet medical needs in psychiatric and neurological disorders, including PTSD, autism, and ADHD. The company was founded by Vlad Bogin and is headquartered in Portland, OR. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| PRECIGEN, INC. | Biotechnology | Corporate Officer/Principal | |
| Vendevia Group | Corporate Officer/Principal | ||
| MarrowTech Pharma, Inc. | General Counsel | ||
| Batu Centre For Leukemia Research | President | ||
LXN Corp
 LXN Corp Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, LXN Corp is a company that develops and commercializes fructosamine monitoring technology for diabetes. The company is based in San Diego, CA. The company was founded by John F. Burd. LXN was acquired by Inverness Medical Technology, Inc. on March 29, 2001 for $18.48 million. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 31 |
| Kanada | 7 |
| China | 3 |
| Neuseeland | 2 |
Sektoral
| Health Technology | 17 |
| Consumer Services | 7 |
| Health Services | 5 |
| Finance | 3 |
| Technology Services | 2 |
Operativ
| President | 14 |
| Director/Board Member | 13 |
| Chief Tech/Sci/R&D Officer | 13 |
| Corporate Officer/Principal | 11 |
| Chairman | 7 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Thomas Ichim | 24 |
| Timothy Dixon | 9 |
| Feng Lin | 8 |
| James Veltmeyer | 6 |
| Serena Robella | 1 |
- Börse
- Insiders
- Famela Ramos
- Unternehmensverbindungen
